+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID06376981

Comparing Corticosteroid Plus Hyaluronic Acid Injection Versus Corticosteroid Alone for Treating Supraspinatus Tendinopathy in Adults

Led by Centre Hospitalier Departemental Vendee · Updated on 2026-07-10

132

Participants Needed

2

Research Sites

169 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of combining corticosteroid and hyaluronic acid injections compared to corticosteroid injections alone for treating supraspinatus tendinopathy in adults. This randomized, multicenter study aims to measure pain during activity at three months, with clinical reevaluations at one, three, and six months. The trial focuses on patients experiencing shoulder tendinitis with pain lasting at least two months. Participants will receive either an injection of 1 ml corticosteroids plus 2 ml hyaluronic acid or 1 ml corticosteroids plus 2 ml placebo physiological serum. These treatments are administered as subacromial injections. The study is double-blind and participants are randomly assigned to one of these two groups. During the study, participants will be monitored at one, three, and six months after treatment to assess pain levels using a visual analog scale ranging from 0 to 100 mm. Researchers will evaluate pain on activity at three months as the primary outcome. Participants medical history, pain assessments, and imaging confirmation of tendinopathy will be part of the evaluation process. The study is expected to complete by March 2030.

CONDITIONS

Brief Title

Hyaluronic Acid in Shoulder Tendinopathy

Research Team

L

Laura SOULARD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here